Clinical Research, Pharma & Healthcare FinancingICON Updates Timing of Q4 & Full Year 2025 Earnings ReportBusiness WireFebruary 12, 2026February 13, 2026 by Business WireFebruary 12, 2026February 13, 2026019 Investigation’s preliminary indications are that 2023 and 2024 revenue may have been overstated by less than 2% for each fiscal year ICON plc, (NASDAQ: ICLR)...